Myeloid sarcoma of bile ducts presenting as obstructive jaundice - A case report

Myeloid sarcoma is an extra medullary manifestation of acute myeloid leukemia (AML). Primary involvement of the biliary tract with myeloid sarcoma presenting as obstructive jaundice without evidence of leukemia is very rare. Here we present a case of 72 year old lady, who initially presented with fe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayushi Agarwal (Author), Tina Dadu (Author), V P Bhalla (Author), Veena Malhotra (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_70b69ad4838a4f19b1aefa6d127619e7
042 |a dc 
100 1 0 |a Ayushi Agarwal  |e author 
700 1 0 |a Tina Dadu  |e author 
700 1 0 |a V P Bhalla  |e author 
700 1 0 |a Veena Malhotra  |e author 
245 0 0 |a Myeloid sarcoma of bile ducts presenting as obstructive jaundice - A case report 
260 |b Wolters Kluwer Medknow Publications,   |c 2019-01-01T00:00:00Z. 
500 |a 0377-4929 
500 |a 10.4103/IJPM.IJPM_371_18 
520 |a Myeloid sarcoma is an extra medullary manifestation of acute myeloid leukemia (AML). Primary involvement of the biliary tract with myeloid sarcoma presenting as obstructive jaundice without evidence of leukemia is very rare. Here we present a case of 72 year old lady, who initially presented with features of biliary obstruction and was clinically considered as cholangiocarcinoma. She was diagnosed as myeloid sarcoma involving right and left hepatic duct, common bile duct (CBD) on histopathological and immunohistochemistry (IHC) examination after surgical resection. Since she did not show evidence of leukemia on peripheral blood and bone marrow examination treatment was deferred. However, she developed full blown picture of AML within two months and succumbed to her disease. We conclude that obstructive jaundice can be the presenting symptom in myeloid sarcoma without evidence of AML in peripheral blood and bone marrow. However, these cases have to be treated aggressively to obtain remission. 
546 |a EN 
690 |a Immunohistochemistry 
690 |a myeloid sarcoma 
690 |a obstructive jaundice 
690 |a Pathology 
690 |a RB1-214 
690 |a Microbiology 
690 |a QR1-502 
655 7 |a article  |2 local 
786 0 |n Indian Journal of Pathology and Microbiology, Vol 62, Iss 4, Pp 602-604 (2019) 
787 0 |n http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2019;volume=62;issue=4;spage=602;epage=604;aulast=Agarwal 
787 0 |n https://doaj.org/toc/0377-4929 
856 4 1 |u https://doaj.org/article/70b69ad4838a4f19b1aefa6d127619e7  |z Connect to this object online.